Lv1
10 积分 2025-09-16 加入
The Right Treatment of the Right Patient: Integrating Genetic Profiling Into Clinical Decision Making in Advanced Gastric Cancer in Asia
1天前
求助中
Perspectives on the pharmacological management of esophageal cancer: where are we now and where do we need to go?
1天前
已完结
[Esophageal cancer: new developments in prevention and therapy]
1天前
已完结
Claudin-18 and Mutation Surrogate Immunohistochemistry in Gastric-type Endocervical Lesions and their Differential Diagnoses
1天前
已完结
Zolbétuximab en association à la chimiothérapie dans les adénocarcinomes gastriques ou de la jonction œsogastrique localement avancés non résécables ou métastatiques, HER2 négatifs et CLDN 18.2 positifs
1天前
求助中
Frequency of MSI, PD-L1 (CPS), HER2 in poorly cohesive gastric carcinomas
1天前
求助中
Guidelines of Onkopedia: What Is New?
1天前
求助中
Claudin 18.2 and Other Therapeutic Biomarkers in Gastric and Gastroesophageal Junction Adenocarcinomas
1天前
已完结
Spatial profiling of patient-matched HER2 positive gastric cancer reveals resistance mechanisms to targeted therapy
1天前
已完结
Histological and biomarker landscape of Claudin18.2-positive gastric and gastroesophageal junction cancers: a study of 937 cases
1天前
已完结
皖公网安备34019202002308
